Vaxart Inc (NASDAQ:VXRT) has a beta value of 0.65 and has seen 1.63 million shares traded in the last trading session. The VXRT stock price is -156.67% off its 52-week high price of $1.54 and 13.33% above the 52-week low of $0.52. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.01 million shares traded. The 3-month trading volume is 1.49 million shares.

The consensus among analysts is that Vaxart Inc (VXRT) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 2 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.11.

Vaxart Inc (NASDAQ:VXRT) trade information

Sporting 0.12% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the VXRT stock price touched $0.60 or saw a rise of 7.69%. Year-to-date, Vaxart Inc shares have moved 4.75%, while the 5-day performance has seen it change 3.43%. Over the past 30 days, the shares of Vaxart Inc (NASDAQ:VXRT) have changed -22.88%. Short interest in the company has seen 11.27 million shares shorted with days to cover at 11.71.

Wall Street analysts have a consensus price target for the stock at $2, which means that the shares’ value could jump 70.0% from current levels. The projected low price target is $2.0 while the price target rests at a high of $2.0. In that case, then, we find that the current price level is -233.33% off the targeted high while a plunge would see the stock gain -233.33% from current levels.

Vaxart Inc (VXRT) estimates and forecasts

Figures show that Vaxart Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -30.75% over the past 6 months, with this year growth rate of 31.58%, compared to 16.70% for the industry. Revenue growth from the last financial year stood is estimated to be 364.62%.

4 analysts offering their estimates for the company have set an average revenue estimate of 15.68M for the current quarter. 3 have an estimated revenue figure of 8.32M for the next ending quarter. Year-ago sales stood 3.25M and 2.18M respectively for this quarter and the next, and analysts expect sales will grow by 383.34% for the current quarter and 364.62% for the next.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 27.81% over the past 5 years.

VXRT Dividends

Vaxart Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Vaxart Inc (NASDAQ:VXRT)’s Major holders

Insiders own 0.87% of the company shares, while shares held by institutions stand at 17.80% with a share float percentage of 17.96%. Investors are also buoyed by the number of investors in a company, with Vaxart Inc having a total of 119.0 institutions that hold shares in the company. The top two institutional holders are SIO CAPITAL MANAGEMENT, LLC with over 14.76 million shares worth more than $9.85 million. As of 2024-06-30, SIO CAPITAL MANAGEMENT, LLC held 8.7465% of shares outstanding.

The other major institutional holder is VANGUARD GROUP INC, with the holding of over 9.95 million shares as of 2024-06-30. The firm’s total holdings are worth over $6.64 million and represent 5.8947% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . As of Jun 30, 2024 , the former fund manager holds about 3.15% shares in the company for having 7.16 shares of worth $4.3 million while later fund manager owns 2.52 shares of worth $1.51 million as of Jun 30, 2024 , which makes it owner of about 1.11% of company’s outstanding stock.